Camp4 Therapeutics Corp (CAMP)
About Camp4 Therapeutics Corp
Camp4 Therapeutics Corp is a clinical-stage biopharmaceutical company pioneering the discovery and development of regulatory RNA-based therapeutics to upregulate gene expression and restore healthy protein levels to treat various genetic diseases. The company focuses on genetic diseases of the central nervous system and liver. Its pipeline products include CMP-CPS-001 and CMP-SYNGAP. The company operates as a single operating segment, R&D, which engages in the development of a new class of RNA-based therapeutics to treat a broad range of genetic diseases.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $3.5M
- Net income
- -$80.4M
- Total assets
- $117.8M
- Market cap
- $213.4M
- Operating margin
- -1502.4%
- Net margin
- -2298.5%
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $3.5M
- Operating expenses
- $56.1M
- Operating income
- -$52.6M
- Income tax
- $0
- Net income
- -$80.4M
- EPS (basic)
- $-2.65
- EPS (diluted)
- $-2.65
Balance sheet
- Total assets
- $117.8M
- Current assets
- $114.1M
- Total liabilities
- $70.1M
- Current liabilities
- $15.5M
- Shareholders’ equity
- $47.7M
Cash flow
- Operating cash flow
- -$29.6M
- Investing cash flow
- -$243.0K
- Financing cash flow
- $75.9M
- Net cash flow
- $46.1M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $213.4M
- EPS (diluted)
- $-2.65
- Shares outstanding
- 67.5M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Oct 11, 2024
Camp4 Therapeutics Corp (CAMP) Stock Price
- Reported a net loss of $80.4M in FY2025.
- Revenue declined 99% from FY2021 to FY2025.
- Trading 56% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Camp4 Therapeutics Corp.
Write a review
News about Camp4 Therapeutics Corp
News & sentiment via Polygon.io
Camp4 Therapeutics Corp: frequently asked questions
Is Camp4 Therapeutics Corp an American company?
Camp4 Therapeutics Corp is a US-based company headquartered in Cambridge, Massachusetts, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Camp4 Therapeutics Corp headquartered?
Camp4 Therapeutics Corp is headquartered in Cambridge, Massachusetts, United States.
Is Camp4 Therapeutics Corp publicly traded?
Yes — Camp4 Therapeutics Corp is a publicly traded company. Its stock trades under the ticker symbol CAMP on the NASDAQ.
What does Camp4 Therapeutics Corp do?
Camp4 Therapeutics Corp is an American Pharmaceuticals company in the Health & Beauty sector.
